ConductScience.org, home

Paper41232829

Impact of SGLT2 inhibitors on long-term outcomes in TAVI patients with heart failure: a propensity-matched analysis.

Obeidat O and 11 others. Rev Esp Cardiol (Engl Ed), 2026. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. Impact of SGLT2 inhibitors on long-term outcomes in TAVI patients with heart failure: a propensity-matched analysis. Papers, record 41232829. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41232829

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Impact of SGLT2 inhibitors on long-term outcomes in TAVI patients with heart failure: a propensity-matched analysis.
PubMed
Journal
Rev Esp Cardiol (Engl Ed)
PubMed
Year
2026
PubMed
Publication types
Journal Article, Multicenter Study
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
3.99, provisional
iCite
Revised in PubMed
2026-06-01
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Obeidat OOmar
2Alayyat AAhmad
3Naser AAbdallah
4Ghanem FFares
5Jabri AAhmad
6Brankovic MMilos
7Jiao TTianze
8Ruzieh MMohammed
9Haddad AAlaq
10Alexy TTamas
11Villablanca PPedro
12Alhuneafat LLaith

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Heart FailureMajor topic
Transcatheter Aortic Valve ReplacementMajor topic
Sodium-Glucose Transporter 2 InhibitorsMajor topic
Aortic Valve StenosisMajor topic
Humans
Male
Retrospective Studies
Female
Propensity Score
Aged, 80 and over
Aged
Treatment Outcome
Time Factors
Follow-Up Studies
Survival Rate

Source PubMed

Download CSV of topics

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
42919410SGLT2 inhibitor therapy following aortic valve intervention for aortic stenosis: a systematic review and meta-analysis of mortality, heart failure, rhythm, renal, and valve-related outcomes.J Cardiothorac Surg2026https://conductscience.org/library/papers/42919410PubMed
42834681Association of Sodium-Glucose Cotransporter 2 Inhibitor Use With Outcomes in Patients Undergoing Transcatheter Aortic Valve Implantation: A Systematic Review and GRADE-Assessed Meta-Analysis.Cardiovasc Ther2026https://conductscience.org/library/papers/42834681PubMed
42433614SGLT2 inhibitors after transcatheter aortic valve implantation: a systematic review and exploratory meta-analysis.Int J Cardiol Heart Vasc2026https://conductscience.org/library/papers/42433614PubMed
42426443Patient overlap and the validity of SGLT2 inhibitor benefits after TAVI: a critique of recent meta-analytical findings.Eur J Clin Pharmacol2026https://conductscience.org/library/papers/42426443PubMed
42335597SGLT-2 Inhibitors and Outcomes After Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-Analysis.JACC Adv2026https://conductscience.org/library/papers/42335597PubMed
42233563SGLT2 Inhibition as a Novel Therapeutic Strategy in Rheumatic Heart Disease.JACC Asia2026https://conductscience.org/library/papers/42233563PubMed
42056230Therapeutic impact of SGLT2 inhibitors following transcatheter aortic valve implantation: a grade-assessed systematic review and meta-analysis.Eur J Clin Pharmacol2026https://conductscience.org/library/papers/42056230PubMed
41901616SGLT2 Inhibitor Therapy and Long-Term Outcomes After Transcatheter Aortic Valve Implantation in Patients with Low Ejection Fraction.Medicina (Kaunas)2026https://conductscience.org/library/papers/41901616PubMed
41598653Assessing Potential Valve-Preserving Effects of SGLT2 Inhibitors in Degenerative Aortic Stenosis: A Propensity-Matched Study.J Clin Med2026https://conductscience.org/library/papers/41598653PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41232829

GET https://conductscience.org/api/papers/v1/41232829/authors